Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
FEIM Quote, Financials, Valuation and Earnings
Last price:
$20.40
Seasonality move
:
-0.97%
Day range:
$19.55 - $20.55
52-week range:
$9.13 - $24.77
Dividend yield:
0%
P/E ratio:
8.25x
P/S ratio:
2.80x
P/B ratio:
3.54x
Volume:
314.4K
Avg. volume:
356.9K
1-year change:
119.85%
Market cap:
$197.2M
Revenue:
$69.8M
EPS (TTM):
$2.47
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $54.3M | $48.3M | $40.8M | $55.3M | $69.8M | |
| Revenue Growth (YoY) | 30.71% | -10.98% | -15.57% | 35.55% | 26.3% | |
| Cost of Revenues | $37.3M | $39.7M | $32.9M | $36.7M | $39.7M | |
| Gross Profit | $16.9M | $8.6M | $7.8M | $18.6M | $30.1M | |
| Gross Profit Margin | 31.19% | 17.81% | 19.25% | 33.62% | 43.11% | |
| R&D Expenses | $4.7M | $5M | $3.1M | $3.4M | $6.1M | |
| Selling, General & Admin | $13.2M | $11.7M | $9.4M | $10.2M | $12.3M | |
| Other Inc / (Exp) | $1.6M | -$547K | -$599K | $554K | -- | |
| Operating Expenses | $17.9M | $16.6M | $12.5M | $13.6M | $18.4M | |
| Operating Income | -$958K | -$8M | -$4.7M | $5M | $11.7M | |
| Net Interest Expenses | $127K | $77K | $156K | $109K | -- | |
| EBT. Incl. Unusual Items | $476K | -$8.7M | -$5.4M | $5.5M | $12.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$204K | $1K | $74K | -$130K | -$11.7M | |
| Net Income to Company | $680K | -$8.7M | -$5.5M | $5.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $680K | -$8.7M | -$5.5M | $5.6M | $23.8M | |
| Basic EPS (Cont. Ops) | $0.07 | -$0.93 | -$0.59 | $0.59 | $2.48 | |
| Diluted EPS (Cont. Ops) | $0.07 | -$0.93 | -$0.59 | $0.59 | $2.48 | |
| Weighted Average Basic Share | $9.2M | $9.3M | $9.3M | $9.4M | $9.6M | |
| Weighted Average Diluted Share | $9.2M | $9.3M | $9.3M | $9.4M | $9.6M | |
| EBITDA | $3.9M | -$5.6M | -$2.8M | $7.7M | $11.7M | |
| EBIT | $603K | -$8.6M | -$5.3M | $5.6M | $11.7M | |
| Revenue (Reported) | $54.3M | $48.3M | $40.8M | $55.3M | $69.8M | |
| Operating Income (Reported) | -$958K | -$8M | -$4.7M | $5M | $11.7M | |
| Operating Income (Adjusted) | $603K | -$8.6M | -$5.3M | $5.6M | $11.7M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $15.6M | $10.2M | $13M | $15.6M | $20M | |
| Revenue Growth (YoY) | 52.8% | -35.05% | 27.99% | 19.78% | 28.31% | |
| Cost of Revenues | $10.9M | $13M | $9M | $9.3M | $12.5M | |
| Gross Profit | $4.7M | -$2.8M | $4M | $6.3M | $7.5M | |
| Gross Profit Margin | 30.09% | -27.49% | 31.06% | 40.33% | 37.49% | |
| R&D Expenses | $1.2M | $1.1M | $657K | $1.1M | $1.5M | |
| Selling, General & Admin | $3.4M | $2M | $3M | $2.7M | $2.7M | |
| Other Inc / (Exp) | $1.1M | -$902K | -$4K | $5K | -- | |
| Operating Expenses | $4.6M | $3.1M | $3.6M | $3.8M | $4.2M | |
| Operating Income | $99K | -$5.9M | $393K | $2.5M | $3.3M | |
| Net Interest Expenses | $43K | $18K | $75K | $23K | $72K | |
| EBT. Incl. Unusual Items | $1.2M | -$6.9M | $314K | $2.5M | $3.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$241K | -$2K | $68K | -$149K | -$106K | |
| Net Income to Company | $1.4M | -$6.9M | $246K | $2.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.4M | -$6.9M | $246K | $2.6M | $3.3M | |
| Basic EPS (Cont. Ops) | $0.15 | -$0.74 | $0.03 | $0.28 | $0.34 | |
| Diluted EPS (Cont. Ops) | $0.15 | -$0.74 | $0.03 | $0.28 | $0.34 | |
| Weighted Average Basic Share | $9.2M | $9.3M | $9.4M | $9.5M | $9.7M | |
| Weighted Average Diluted Share | $9.5M | $9.3M | $9.4M | $9.5M | $9.7M | |
| EBITDA | $1.2M | -$6.8M | $389K | $2.5M | $3.3M | |
| EBIT | $1.2M | -$6.8M | $389K | $2.5M | $3.3M | |
| Revenue (Reported) | $15.6M | $10.2M | $13M | $15.6M | $20M | |
| Operating Income (Reported) | $99K | -$5.9M | $393K | $2.5M | $3.3M | |
| Operating Income (Adjusted) | $1.2M | -$6.8M | $389K | $2.5M | $3.3M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $54.3M | $48.3M | $40.8M | $55.3M | $69.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $37.3M | $39.7M | $32.9M | $36.7M | $39.7M | |
| Gross Profit | $16.9M | $8.6M | $7.8M | $18.6M | $30.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.7M | $5M | $3.1M | $3.4M | $6.1M | |
| Selling, General & Admin | $13.2M | $11.7M | $9.4M | $10.2M | $12.3M | |
| Other Inc / (Exp) | $1.6M | -$547K | -$600K | $555K | $564K | |
| Operating Expenses | $17.9M | $16.6M | $12.5M | $13.6M | $18.4M | |
| Operating Income | -$958K | -$8M | -$4.7M | $5M | $11.7M | |
| Net Interest Expenses | $127K | $77K | $156K | $110K | $151K | |
| EBT. Incl. Unusual Items | $477K | -$8.7M | -$5.4M | $5.5M | $12.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$203K | $2K | $73K | -$130K | -$11.7M | |
| Net Income to Company | $680K | -$8.7M | -$5.5M | $5.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $680K | -$8.7M | -$5.5M | $5.6M | $23.8M | |
| Basic EPS (Cont. Ops) | $0.07 | -$0.94 | -$0.58 | $0.59 | $2.47 | |
| Diluted EPS (Cont. Ops) | $0.07 | -$0.94 | -$0.58 | $0.59 | $2.47 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $604K | -$8.6M | -$5.3M | $5.6M | $12.3M | |
| EBIT | $604K | -$8.6M | -$5.3M | $5.6M | $12.3M | |
| Revenue (Reported) | $54.3M | $48.3M | $40.8M | $55.3M | $69.8M | |
| Operating Income (Reported) | -$958K | -$8M | -$4.7M | $5M | $11.7M | |
| Operating Income (Adjusted) | $604K | -$8.6M | -$5.3M | $5.6M | $12.3M | |
| Period Ending | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2026-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $48.3M | $40.8M | $55.3M | $69.8M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $39.7M | $32.9M | $36.7M | $39.7M | -- | |
| Gross Profit | $8.6M | $7.8M | $18.6M | $30.1M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $5M | $3.1M | $3.4M | $6.1M | -- | |
| Selling, General & Admin | $11.7M | $9.4M | $10.2M | $12.3M | -- | |
| Other Inc / (Exp) | -$547K | -$600K | $555K | $564K | -- | |
| Operating Expenses | $16.6M | $12.5M | $13.6M | $18.4M | -- | |
| Operating Income | -$8M | -$4.7M | $5M | $11.7M | -- | |
| Net Interest Expenses | $77K | $156K | $110K | $151K | -- | |
| EBT. Incl. Unusual Items | -$8.7M | -$5.4M | $5.5M | $12.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2K | $73K | -$130K | -$11.7M | -- | |
| Net Income to Company | -$8.7M | -$5.5M | $5.6M | $20.5M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$8.7M | -$5.5M | $5.6M | $23.8M | -- | |
| Basic EPS (Cont. Ops) | -$0.94 | -$0.58 | $0.59 | $2.47 | -- | |
| Diluted EPS (Cont. Ops) | -$0.94 | -$0.58 | $0.59 | $2.47 | -- | |
| Weighted Average Basic Share | $37M | $37.3M | $37.7M | $38.4M | -- | |
| Weighted Average Diluted Share | $37.1M | $37.3M | $37.7M | $38.4M | -- | |
| EBITDA | -$8.6M | -$5.3M | $5.6M | $12.3M | -- | |
| EBIT | -$8.6M | -$5.3M | $5.6M | $12.3M | -- | |
| Revenue (Reported) | $48.3M | $40.8M | $55.3M | $69.8M | -- | |
| Operating Income (Reported) | -$8M | -$4.7M | $5M | $11.7M | -- | |
| Operating Income (Adjusted) | -$8.6M | -$5.3M | $5.6M | $12.3M | -- | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.8M | $11.6M | $12M | $18.3M | $4.7M | |
| Short Term Investments | $10.3M | $10M | -- | -- | -- | |
| Accounts Receivable, Net | $5.5M | $4.3M | $4.6M | $4.6M | $5.9M | |
| Inventory | $19.7M | $19.9M | $20.5M | $23.4M | $23.5M | |
| Prepaid Expenses | $444K | $269K | $30K | $37K | -- | |
| Other Current Assets | $991K | $1.2M | $1.1M | $1.2M | $1.1M | |
| Total Current Assets | $61.2M | $56M | $48.3M | $58.1M | $53.1M | |
| Property Plant And Equipment | $19.4M | $17.4M | $14.5M | $12.5M | $14.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $617K | $617K | $617K | $617K | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $17.3M | $10.8M | $11.1M | $12M | $13.7M | |
| Total Assets | $98.5M | $84.8M | $74.5M | $83.3M | $93.9M | |
| Accounts Payable | $1.1M | $1.1M | $1.5M | $2.3M | -- | |
| Accrued Expenses | $1.8M | $973K | $719K | $756K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.7M | $1.7M | $1.8M | $1.6M | $2M | |
| Other Current Liabilities | -- | -- | -- | -- | $7.9M | |
| Total Current Liabilities | $20.6M | $21.9M | $27.3M | $30.8M | $23.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43.1M | $38.1M | $41.6M | $43.4M | $38.1M | |
| Common Stock | $9.2M | $9.3M | $9.4M | $9.5M | -- | |
| Other Common Equity Adj | $291K | -$440K | -- | -- | -- | |
| Common Equity | $55.4M | $46.7M | $32.9M | $39.8M | $55.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $55.4M | $46.7M | $32.9M | $39.8M | $55.7M | |
| Total Liabilities and Equity | $98.5M | $84.8M | $74.5M | $83.3M | $93.9M | |
| Cash and Short Terms | $20.1M | $21.5M | $12M | $18.3M | $4.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.8M | $11.6M | $12M | $18.3M | $4.7M | |
| Short Term Investments | $10.3M | $10M | -- | -- | -- | |
| Accounts Receivable, Net | $5.5M | $4.3M | $4.6M | $4.6M | $5.9M | |
| Inventory | $19.7M | $19.9M | $20.5M | $23.4M | $23.5M | |
| Prepaid Expenses | $444K | $269K | $30K | $37K | -- | |
| Other Current Assets | $991K | $1.2M | $1.1M | $1.2M | $1.1M | |
| Total Current Assets | $61.2M | $56M | $48.3M | $58.1M | $53.1M | |
| Property Plant And Equipment | $19.4M | $17.4M | $14.5M | $12.5M | $14.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $617K | $617K | $617K | $617K | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $17.3M | $10.8M | $11.1M | $12M | $13.7M | |
| Total Assets | $98.5M | $84.8M | $74.5M | $83.3M | $93.9M | |
| Accounts Payable | $1.1M | $1.1M | $1.5M | $2.3M | -- | |
| Accrued Expenses | $1.8M | $973K | $719K | $756K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.7M | $1.7M | $1.8M | $1.6M | $2M | |
| Other Current Liabilities | -- | -- | -- | -- | $7.9M | |
| Total Current Liabilities | $20.6M | $21.9M | $27.3M | $30.8M | $23.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43.1M | $38.1M | $41.6M | $43.4M | $38.1M | |
| Common Stock | $9.2M | $9.3M | $9.4M | $9.5M | -- | |
| Other Common Equity Adj | $291K | -$440K | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $55.4M | $46.7M | $32.9M | $39.8M | $55.7M | |
| Total Liabilities and Equity | $98.5M | $84.8M | $74.5M | $83.3M | $93.9M | |
| Cash and Short Terms | $20.1M | $21.5M | $12M | $18.3M | $4.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10M | $680K | -$8.7M | -$5.5M | $5.6M | |
| Depreciation & Amoritzation | $3.3M | $3.3M | $3M | $2.4M | $2.1M | |
| Stock-Based Compensation | $312K | $273K | $247K | $197K | $822K | |
| Change in Accounts Receivable | $1.3M | -$4.8M | $7M | -$1.4M | -$358K | |
| Change in Inventories | $17K | $3M | -$464K | -$1.2M | -$3.8M | |
| Cash From Operations | -$1.4M | $12.2M | $4M | $1.2M | $8.7M | |
| Capital Expenditures | $1.5M | $1.2M | $1.9M | $918K | $1.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.4M | -$1.2M | -$2.3M | $8.7M | -$1.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$9.4M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$5M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $5M | -$5M | -- | -$9.4M | -- | |
| Beginning Cash (CF) | $3.7M | $3.8M | $9.8M | $11.6M | $12M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $125K | $6M | $1.8M | $488K | $7.2M | |
| Ending Cash (CF) | $3.8M | $9.8M | $11.6M | $12M | $19.3M | |
| Levered Free Cash Flow | -$2.9M | $10.9M | $2.2M | $257K | $7.2M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $680K | -$8.7M | -$5.5M | $5.6M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $12.2M | $4M | $1.2M | $8.7M | -- | |
| Capital Expenditures | $1.2M | $1.9M | $918K | $1.5M | $1.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.2M | -$2.3M | $8.7M | -$1.5M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$9.4M | -- | -$9.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$5M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$5M | -- | -$9.4M | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6M | $1.8M | $488K | $7.2M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $10.9M | $2.2M | $257K | $7.2M | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get FEIM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FEIM
Sector
P/E ratio
8.25x
23.75x
PEG ratio
0.03x
0.00x
P/B ratio
3.54x
2.35x
Price / LTM sales
2.80x
1.66x
Growth Metrics
FEIM
Sector
Revenue growth
28.31%
3.91%
Earnings growth
21.43%
11.1%
Revenue (5-year growth)
10.96%
6.27%
Earnings forecast
$0.27
$0.12
Profitability
FEIM
Sector
Profitability FY 2025
$30.1M
$76.5M
Return on invested capital
54.9%
0.05%
Return on assets
27.96%
-0.48%
Return on equity
54.9%
0.73%
Earnings Date
Last Earnings Date
Jul
10
Next Earnings Date
Sep
10
Estimated Next Earnings Date
Oct
9
Balance Sheet
FEIM
Sector
Total cash
$4.7M
$48.7M
Short term investments
--
$19.4M
Total assets
$93.9M
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
